Prognostic factors in elderly patients with acute myeloid leukemia

Author:

Poštić Anka,Virijević Marijana

Abstract

Introduction: Acute myeloid leukemia (AML) is characterized by pathological proliferation of myeloid lineages. It predominantly occurs in patients over 60 years of age, whose outcome is considerably worse, as compared to younger patients. Aim: The aim of the study was the analysis of the clinical characteristics of older patients with AML and their impact on the following: achieving complete remission (CR), overall survival (OS), early mortality (EM), and relapse. Materials and methods: This retrospective study included 94 patients with AML, treated with chemotherapy and palliative treatment, whose information was taken from their medical histories, upon treatment. The following clinical features were analyzed as risk factors for OS, CR, relapse and EM: leukocytes, the level of serum lactate dehydrogenase (LDH), performance status on the ECOG (Eastern Cooperative Oncology Group) scale, the European LeukemiaNet cytoplasmic risk group, the HCT-CI (hematopoietic cell transplantation - comorbidity index) and the NPM1/ FLT3-ITD (nucleophosmin 1/FLT3-internal tandem mutation) molecular status. For the identification of prognostic factors, the Cox regression analysis was used. Results: The average age of the patients was 69 years (range: 65 - 87). CR was achieved in 23 (46%) of the 50 patients (53.2%) who received intensive chemotherapy, with relapse occurring in 17/23 patients (73.9%). EM was reported in 17 patients (18.1%). Patients with ECOG PS > 2 had a statistically significantly lower OS than patients with ECOG PS < 2 (p = 0.030). Patients with HCT-CI > 3 had a poorer OS than patients with HCT-CI < 3 (p = 0.040). Serum LDH > 450 U/I was found to be a factor, i.e., marker of unfavorable prognosis for the OS, as compared to LDH < 450U/I (p = 0.044). Conclusion: The conclusion is that older AML patients with poorer ECOG PS, high HCT-CI, increased LDH levels have a poorer OS.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Reference25 articles.

1. Janković G. Akutna mijeloblastna leukemija. In: Ćolović M, Janković G. Maligne bolesti krvi. Beograd, Zavod za udžbenike i nastavna sredstva, 1999: 81-119;

2. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975-2005. SEER Database, National Cancer Institute; 2009;

3. Hiddemann W, Kern W, Schoch C, Fonatsch C, Heinecke A, Wörmann B, et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol. 1999 Nov;17(11):3569-76;

4. Stone RM. The difficult problem of acute myeloid leukemia in older adult. CA Cancer J Clin. 2002;52:363-71;

5. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006 May 1;

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3